Latest news
Eli Lilly Locks In Retatrutide FDA Filing Date — Can the Stock Climb to $1,750 by 2027? - NAI500NAI500 · Sat, 08 Aug 2026 02:03:05 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 22:50:00 GMTFDA panel to review Grail's blood-based cancer test - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 21:32:11 GMTXenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 18:03:22 GMTCo-Diagnostics Submits FDA Notification for Upper Respiratory Multiplex Test - Clinical Lab ProductsClinical Lab Products · Thu, 06 Aug 2026 14:43:11 GMTSpotlight On: Lilly reiterates BLA route for next-gen obesity drug and expects to find common ground with FDA on filing plans - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 14:31:57 GMTModerna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock - BioSpaceBioSpace · Thu, 06 Aug 2026 11:52:35 GMTModerna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 03:36:50 GMT